Shawnte Mitchell - 03 Mar 2026 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF LEGAL OFFICER
Signature: /s/ Shawnte Mitchell
Issuer symbol: OLMA
Transactions as of: 03 Mar 2026
Net transactions value: -$951,503
Form type: 4
Filing time: 05 Mar 2026, 20:00:07 UTC
Previous filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mitchell Shawnte	CHIEF LEGAL OFFICER	C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO	/s/ Shawnte Mitchell	05 Mar 2026	0001749432

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise		+15,000		$4.37^*	15,000	03 Mar 2026	Direct
transaction	OLMA	Common Stock	Sale	$345,150	-15,000	-100%	$23.01	0	03 Mar 2026	Direct	F1
transaction	OLMA	Common Stock	Options Exercise		+25,000		$4.37^*	25,000	04 Mar 2026	Direct
transaction	OLMA	Common Stock	Sale	$600,600	-24,767	-99%	$24.25	233	04 Mar 2026	Direct	F2
transaction	OLMA	Comon Stock	Sale	$5,753	-233	-100%	$24.69	0	04 Mar 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise		-15,000	-3.3%	$0.000000^*	435,000	03 Mar 2026	Common Stock	15,000	$4.37	Direct	F4
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise		-25,000	-5.7%	$0.000000^*	410,000	04 Mar 2026	Common Stock	25,000	$4.37	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The weighted average sale price for the transaction reported was $23.01, and the range of prices were between $22.89 and $23.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F2	The weighted average sale price for the transaction reported was $24.25, and the range of prices were between $23.68 and $24.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3	The weighted average sale price for the transaction reported was $24.69, and the range of prices were between $24.68 and $24.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4	25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.